Start with the hormone question, not the scan alone
A pituitary tumor is not one disease. A prolactinoma, a growth-hormone-secreting adenoma, an ACTH-secreting tumor and a non-functioning mass can lead to very different plans. The first decision is therefore not 'which hospital' but 'what type of tumor does the evidence show, and is it producing excess hormone or pressing on nearby structures?'
That distinction changes everything downstream. Some prolactin-secreting tumors are managed with medication rather than an operation, while other functioning tumors may be considered for surgery. A non-functioning tumor that is not causing pressure symptoms may be watched. These are general possibilities, not a recommendation for any individual. The treating endocrinologist and neurosurgeon must interpret the actual results.
So gather the hormone blood tests you already have, with the laboratory's reference ranges and the date and time of sampling. Ask whether dynamic testing was done and whether results were repeated. If hormone testing has not been done, ask the receiving clinician which tests are appropriate rather than ordering a panel yourself. Steroid medicines, pregnancy and other conditions can affect these results, and the clinical team needs that context.
Clarify what the imaging actually shows
Pituitary imaging is usually interpreted alongside hormone and vision findings, not in isolation. Ask for the radiology report and the images themselves, not only a summary line. The report should describe the size and position of any mass, its relationship to the optic chiasm and cavernous sinuses, and whether it is described as an adenoma or something else.
A key question for the treating team is whether the imaging is adequate for surgical planning or whether further imaging is needed. Do not assume that a scan done elsewhere will be accepted unchanged; ask the hospital what it requires. If a scan is older, ask whether it still reflects the current clinical picture.
It also helps to separate what is confirmed from what is suspected. A radiology impression is not a tissue diagnosis. If the plan depends on knowing the tumor type, ask whether surgery or biopsy is being proposed partly to obtain that information, and what the alternatives are.
Ask whether vision and other pressure symptoms have been assessed
Tumors that grow upward can compress the optic chiasm, and patients may notice reduced peripheral vision, difficulty reading or other visual changes. Formal visual field testing and a fundus examination by an ophthalmologist give the treating team information that a patient's own description cannot replace. Ask whether this assessment has been done and whether it should be repeated before treatment.
Other pressure-related questions matter too: headaches, changes in pituitary function, and in larger tumors, symptoms related to surrounding structures. These should be described to the clinical team rather than self-interpreted. If vision is worsening quickly or new neurological symptoms appear, that is a reason to seek urgent local assessment rather than continue planning a routine overseas trip.
For an overseas patient, ask how the hospital will repeat or review these tests and whether the results will be available before a treatment decision. The answer affects how many visits are realistically needed, but the hospital, not this article, should confirm its own scheduling.
Settle the treatment goal and the alternatives in writing
Before committing, ask the team to state the goal in plain terms: to control hormone excess, to relieve pressure on the optic nerves, to obtain tissue for diagnosis, or a combination. Then ask what the alternatives are and why one is preferred for this patient. For a prolactinoma, ask specifically whether medical treatment is an option and how response would be monitored. For a tumor being considered for surgery, ask about the proposed approach, the expected extent of removal and what happens if hormone levels remain abnormal afterwards.
Ask who will make the final decision and which specialties are involved. Pituitary care often involves endocrinology, neurosurgery, ophthalmology and sometimes radiotherapy or pathology. A multidisciplinary review can be useful for complex cases, but it does not guarantee acceptance or a particular outcome. If you are considering a records-based opinion before travelling, understand that it is an opinion based on the documents provided, not a final procedural clearance.
Write down the answers. A short list of confirmed points, open questions and who will answer each one is more useful than a long general checklist.
- What is the working diagnosis, and what evidence supports it?
- What is the treatment goal, and what are the alternatives?
- Which specialties will review the case, and when?
- What would make the team change the plan?
- What follow-up and hormone monitoring are anticipated?
Review medicines and hormone replacement before any plan
Patients often arrive with medicines that affect hormone testing or surgical risk: dopamine agonists, steroid replacement, thyroid hormone, desmopressin, anticoagulants or treatments for other conditions. Do not stop or change any of these on your own. Instead, list every medicine, dose, frequency and reason, and ask the treating team which ones need review before testing or treatment.
Ask specifically whether any current medicine could affect the interpretation of hormone results, and whether the timing of tests needs to change. Also ask how hormone replacement will be managed around any operation or hospital stay. These are clinical decisions for the treating clinicians, and the answers depend on the individual case.
For international patients, medicine availability and import rules are separate practical questions. Ask the hospital and a qualified pharmacist about what can be prescribed or supplied locally, and check the applicable customs rules with the relevant authority. A coordination service does not decide these matters.
Decide what to ask the hospital and what to send first
You do not need to send a complete medical archive to make an initial enquiry. A brief summary is enough to start: the working diagnosis, the main question, key hormone results, the most recent imaging report and any vision assessment. After first contact, the team can explain which additional documents are relevant. Do not send passport numbers or payment details through an initial enquiry form.
Ask the hospital, through its international office or the coordinating team, what its written plan and quote would cover for this specific case. Fee scope, ward options, interpretation arrangements and follow-up scheduling should be confirmed by the provider rather than assumed. Our coordination fees are separate from hospital charges, and a proxy consultation is optional, not a prerequisite for an appointment.
The practical next step is to write a one-page summary of the diagnosis, hormone results, imaging, vision findings, current medicines and your main question, then request a free initial case review. That review checks what is available and what is missing; it does not diagnose, promise acceptance or replace the hospital's assessment. The hospital decides suitability and the treatment plan.
Sources & scope of this guide
References and official service information relevant to this guide.
- neurosurgery
- ophthalmology
- radiotherapy
- Related treatment reference
- payment
- Pituitary Tumors Treatment (PDQ®) - NCI
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
